TAC1 and schizophrenia: Plasma substance P levels were not different between 43 patients with schizophrenia and 34 healthy controls31 and between 42 medication‐naive patients with MDD and 57 healthy controls,40 which has become primary investigations for the association of substance P with schizophrenia and MDD.